Figure 2:

[A] Pulmonary capillary wedge pressure (PCWP) at rest and during exercise prior to treatment and following 24 weeks of treatment with placebo (left panels, blue) or dapagliflozin (right panels, orange). [B] Changes in PCWP at rest and exercise compared to the baseline cardiac catheterization in patients treated with placebo (blue) or dapagliflozin (orange). Error bars in panel [A] reflect standard deviation and [B] Tukey box plots represent median and interquartile range with whiskers representing minimum and maximum values, with individual patient data superimposed.